Journal profile · Virology
Current HIV Research
ISSN 1570-162X · eISSN 1873-4251 · Bentham Science Publishers B.V. · NETHERLANDS · Quarterly · Founded 2003
Current HIV Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.84; hybrid open access; median 115 days to acceptance (78 articles, last 24 months); community-reported acceptance: fairly easy; 52 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current HIV Research is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV Research and Treatment, HIV/AIDS drug development and treatment and HIV/AIDS Research and Interventions, together about 53% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.
Source: LetPub
Research area (LetPub): Virology
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV Research and TreatmentImmunology and Microbiology26%
- HIV/AIDS drug development and treatmentMedicine14.1%
- HIV/AIDS Research and InterventionsMedicine13%
- HIV-related health complications and treatmentsMedicine10.8%
- Adolescent Sexual and Reproductive HealthHealth Professions3%
- HIV, Drug Use, Sexual RiskMedicine2.9%
- Biological Research and Disease StudiesBiochemistry, Genetics and Molecular Biology2.6%
- Immune Cell Function and InteractionImmunology and Microbiology2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.84LetPub ·
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.27LetPub ·
- SNIP 2026-06
- 0.28LetPub ·
- h-index
- 46LetPub ·
- h-index
- 70OpenAlex ·
- i10-index
- 642OpenAlex ·
- 2-year mean citedness
- 1.06OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 12.5%LetPub ·
Volume
- Articles per year
- 62LetPub ·
Articles by year OpenAlex count · 1,464 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 2 | 4 |
| 2025 | 52 | 16 | 60 |
| 2024 | 49 | 7 | 86 |
| 2023 | 47 | 4 | 119 |
| 2022 | 55 | 3 | 144 |
| 2021 | 59 | 12 | 254 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
115 daysMedian, submission to acceptance · P25–P75 90 days – 147 days
- Acceptance to online
- median 169 days (78 articles)
- Submission to online
- median 289 days
- Sample
- 78 articles with submission and acceptance dates (111 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham Science Publishers B.V.
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 2003
- ISSN
- 1570-162X
- Electronic ISSN
- 1873-4251
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current HIV Research
What CAS zone is Current HIV Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current HIV Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology / Infectious Diseases / Virology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current HIV Research?
The latest impact factor listed by LetPub is 0.84; CiteScore 1.5, h-index 70.
How long does peer review take at Current HIV Research?
Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 90–147 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current HIV Research?
According to LetPub and DOAJ records, Current HIV Research is indexed in SCIE and Scopus.
Is Current HIV Research open access, and what is the APC?
Current HIV Research is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .